全文获取类型
收费全文 | 269篇 |
免费 | 14篇 |
国内免费 | 1篇 |
专业分类
基础医学 | 138篇 |
口腔科学 | 2篇 |
临床医学 | 6篇 |
内科学 | 35篇 |
神经病学 | 11篇 |
特种医学 | 3篇 |
外科学 | 1篇 |
综合类 | 36篇 |
预防医学 | 37篇 |
药学 | 11篇 |
中国医学 | 3篇 |
肿瘤学 | 1篇 |
出版年
2023年 | 2篇 |
2022年 | 8篇 |
2021年 | 8篇 |
2020年 | 3篇 |
2019年 | 1篇 |
2018年 | 3篇 |
2017年 | 3篇 |
2016年 | 2篇 |
2015年 | 15篇 |
2014年 | 6篇 |
2013年 | 19篇 |
2012年 | 17篇 |
2011年 | 12篇 |
2010年 | 10篇 |
2009年 | 17篇 |
2008年 | 27篇 |
2007年 | 25篇 |
2006年 | 23篇 |
2005年 | 17篇 |
2004年 | 13篇 |
2003年 | 12篇 |
2002年 | 8篇 |
2001年 | 4篇 |
2000年 | 4篇 |
1999年 | 5篇 |
1998年 | 2篇 |
1996年 | 3篇 |
1995年 | 4篇 |
1994年 | 3篇 |
1993年 | 4篇 |
1992年 | 2篇 |
1991年 | 1篇 |
1985年 | 1篇 |
排序方式: 共有284条查询结果,搜索用时 15 毫秒
11.
Jo?o Dinis de Sousa Carolina Alvarez Anne-Mieke Vandamme Viktor Müller 《Viruses》2012,4(10):1950-1983
HIV-1 M originated from SIVcpz endemic in chimpanzees from southeast Cameroon or neighboring areas, and it started to spread in the early 20th century. Here we examine the factors that may have contributed to simian-to-human transmission, local transmission between humans, and export to a city. The region had intense ape hunting, social disruption, commercial sex work, STDs, and traffic to/from Kinshasa in the period 1899–1923. Injection treatments increased sharply around 1930; however, their frequency among local patients was far lower than among modern groups experiencing parenteral HIV-1 outbreaks. Recent molecular datings of HIV-1 M fit better the period of maximal resource exploitation and trade links than the period of high injection intensity. We conclude that although local parenteral outbreaks might have occurred, these are unlikely to have caused massive transmission. World War I led to additional, and hitherto unrecognized, risks of HIV-1 emergence. We propose an Enhanced Heterosexual Transmission Hypothesis for the origin of HIV-1 M, featuring at the time and place of its origin a coincidence of favorable co-factors (ape hunting, social disruption, STDs, and mobility) for both cross-species transmission and heterosexual spread. Our hypothesis does not exclude a role for parenteral transmission in the initial viral adaptation. 相似文献
12.
《Vaccine》2015,33(27):3073-3083
The use of a number of non-rhesus macaque species, but especially cynomolgus macaques as a model for HIV-1 vaccine development has increased in recent years. Cynomolgus macaques have been used in the United Kingdom, Europe, Canada and Australia as a model for HIV vaccine development for many years. Unlike rhesus macaques, cynomolgus macaques infected with SIV show a pattern of disease pathogenesis that more closely resembles that of human HIV-1 infection, exhibiting lower peak and set-point viral loads and slower progression to disease with more typical AIDS defining illnesses. Several advances have been made recently in the use of the cynomolgus macaque SIV challenge model that allow the demonstration of vaccine efficacy using attenuated viruses and vectors that are both viral and non-viral in origin. This review aims to probe the details of various vaccination trials carried out in cynomolgus macaques in the context of our modern understanding of the highly diverse immunogenetics of this species with a view to understanding the species-specific immune correlates of protection and the efficacy of vectors that have been used to design vaccines. 相似文献
13.
Recent advances in the immunology, pathogenesis, and prevention of human immunodeficiency virus (HIV) infection continue to reveal clues to the mechanisms involved in the progressive immunodeficiency attributed to infection, but more importantly have shed light on the correlates of immunity to infection and disease progression. HIV selectively infects, eliminates, and/or dysregulates several key cells of the human immune system, thwarting multiple arms of the host immune response, and inflicting severe damage to mucosal barriers, resulting in tissue infiltration of ‘symbiotic’ intestinal bacteria and viruses that essentially become opportunistic infections promoting systemic immune activation. This leads to activation and recruitment or more target cells for perpetuating HIV infection, resulting in persistent, high-level viral replication in lymphoid tissues, rapid evolution of resistant strains, and continued evasion of immune responses. However, vaccine studies and studies of spontaneous controllers are finally providing correlates of immunity from protection and disease progression, including virus-specific CD4+ T-cell responses, binding anti-bodies, innate immune responses, and generation of antibodies with potent antibody-dependent cell-mediated cytotoxicity activity. Emerging correlates of immunity indicate that prevention of HIV infection may be possible through effective vaccine strategies that protect and stimulate key regulatory cells and immune responses in susceptible hosts. Furthermore, immune therapies specifically directed toward boosting specific aspects of the immune system may eventually lead to a cure for HIV-infected patients. 相似文献
14.
Lianna F. Wood Ann Chahroudi Hui-Ling Chen Heather B. Jaspan Donald L. Sodora 《Immunological reviews》2013,254(1):34-53
The global spread of human immunodeficiency virus (HIV) is dependent on the ability of this virus to efficiently cross from one host to the next by traversing a mucosal membrane. Unraveling how mucosal exposure of HIV results in systemic infection is critical for the development of effective therapeutic strategies. This review focuses on understanding the immune events associated with the oral route of transmission (via breastfeeding or sexual oral intercourse), which occurs across the oral and/or gastrointestinal mucosa. Studies in both humans and simian immunodeficiency virus (SIV) monkey models have identified viral changes and immune events associated with oral HIV/SIV exposure. This review covers our current knowledge of HIV oral transmission in both infants and adults, the use of SIV models in understanding early immune events, oral immune factors that modulate HIV/SIV susceptibility (including mucosal inflammation), and interventions that may impact oral HIV transmission rates. Understanding the factors that influence oral HIV transmission will provide the foundation for developing immune therapeutic and vaccine strategies that can protect both infants and adults from oral HIV transmission. 相似文献
15.
目的 调查研究从老挝引种的食蟹猴BV、SRV、SIV和STLV-1四项病毒抗体阳性、可疑的比例,并对SPF种群建立过程中四项病毒的动态变化进行了监测,进而比较普通种群和SPF种群幼猴病毒抗体的阳性率。 方法 采用专用试剂盒对四项病毒进行连续监测并进行比较分析。 结果 引种的1998只食蟹猴,BV抗体阳性比例高达52.35%,可疑比例为8.31%,抗体阴性的比例仅为39.34%;SRV和STLV-1抗体阳性率分别为7.45%和8.56%;未检测出SIV抗体阳性或可疑的食蟹猴。经过筛选后组建的SPF种群,2010年监测的BV、SRV和STLV-1三项病毒抗体阳性率分别为5.24%、1.01%和0.4%,经过连续5年的不断筛选和淘汰,截至2014年年底三种病毒抗体阳性率分别下降至0.82%、0.27%和0.27%,未监测出SIV抗体阳性或可疑的食蟹猴。普通群繁殖幼猴B病毒抗体阳性的比例为9.71%,可疑率为1.85%;而SPF繁殖种群B病毒抗体阳性率仅为0.22%。 结论 连续监测病毒抗体并不断淘汰抗体阳性和可疑的动物对组建SPF食蟹猴种群具有重要的生产意义。 相似文献
16.
目的:建立一种简单、经济、高效地培养恒河猴外周血单核巨噬细胞(monocyte-derived macrophage,MDM)的方法。方法:用肝素钠抗凝管采集健康成年中国恒河猴(Macaca mulatta)全血,密度梯度离心法分离外周血单核细胞(peripheral blood mononuclear cells, PBMCs)。同时用无抗凝剂采血管采集同一只猴外周血,自凝后分离血清。将猴PBMCs置于CELLBIND Surface的96孔(0.8×106个细胞/孔)或48孔培养板(3×106个细胞/孔)中,用含不同百分比的猴自体血清或胎牛血清(fetal calf serum,FCS)的RPMI 1640培养液培养24h后洗弃未贴壁细胞,加入含有猴自体血清或FCS的新鲜培养基继续培养7天后观察细胞形态学。分化良好的猴单核巨噬细胞贴壁能力强,占据板底大部分区域。胞体形态多样,多数呈长梭形。用巨噬细胞标记受体(CD14)抗体染色判断细胞纯度。并用细菌内毒素(LPS)刺激分化的巨噬细胞,检测巨噬细胞炎性因子的表达。此外,用猴艾滋病毒(SIVmac17E-Br、SIVmac251)和人-猴嵌合体艾滋病毒(SHIV KU-1)感染分化良好的猴巨噬细胞,检测病毒在猴巨噬细胞中的复制。结果:在含2%猴自体血清的RPMI 1640培养条件下,大多数(>85%)猴单核细胞能在24h内贴壁,体外分化5-7天后,猴巨噬细胞纯度大于96%。相比而言,含较高浓度(4%,8%或10%)猴自体血清或FCS的RPMI 1640 培养基对猴单核细胞的贴壁和分化作用较差。分化良好的猴巨噬细胞对LPS刺激敏感,可产生多种巨噬细胞炎性因子。此外,这些细胞对SIV或SHIV均易感,产生感染性病毒。结论:含2%猴自体血清的RPMI 1640培养基适于原代猴单核细胞的贴壁和分化。该方法简单、花费少,无需生长因子,且分化效果好,是培养猴艾滋病毒及开展相关免疫学实验的重要手段。 相似文献
17.
Meng Niu Brenda Morsey Benjamin G. Lamberty Katy Emanuel Fang Yu Rosiris Len-Rivera Joan W. Berman Peter J. Gaskill Stephanie M. Matt Pawel S. Ciborowski Howard S. Fox 《Viruses》2020,12(11)
Both substance use disorder and HIV infection continue to affect many individuals. Both have untoward effects on the brain, and the two conditions often co-exist. In the brain, macrophages and microglia are infectable by HIV, and these cells are also targets for the effects of drugs of abuse, such as the psychostimulant methamphetamine. To determine the interaction of HIV and methamphetamine, we isolated microglia and brain macrophages from SIV-infected rhesus monkeys that were treated with or without methamphetamine. Cells were subjected to single-cell RNA sequencing and results were analyzed by statistical and bioinformatic analysis. In the animals treated with methamphetamine, a significantly increased proportion of the microglia and/or macrophages were infected by SIV. In addition, gene encoding functions in cell death pathways were increased, and the brain-derived neurotropic factor pathway was inhibited. The gene expression patterns in infected cells did not cluster separately from uninfected cells, but clusters comprised of microglia and/or macrophages from methamphetamine-treated animals differed in neuroinflammatory and metabolic pathways from those comprised of cells from untreated animals. Methamphetamine increases CNS infection by SIV and has adverse effects on both infected and uninfected microglia and brain macrophages, highlighting the dual and interacting harms of HIV infection and drug abuse on the brain. 相似文献
18.
19.
Kaur A Sanford HB Garry D Lang S Klumpp SA Watanabe D Bronson RT Lifson JD Rosati M Pavlakis GN Felber BK Knipe DM Desrosiers RC 《Virology》2007,357(2):199-214
The immunogenicity and protective capacity of replication-defective herpes simplex virus (HSV) vector-based vaccines were examined in rhesus macaques. Three macaques were inoculated with recombinant HSV vectors expressing Gag, Env, and a Tat-Rev-Nef fusion protein of simian immunodeficiency virus (SIV). Three other macaques were primed with recombinant DNA vectors expressing Gag, Env, and a Pol-Tat-Nef-Vif fusion protein prior to boosting with the HSV vectors. Robust anti-Gag and anti-Env cellular responses were detected in all six macaques. Following intravenous challenge with wild-type, cloned SIV239, peak and 12-week plasma viremia levels were significantly lower in vaccinated compared to control macaques. Plasma SIV RNA in vaccinated macaques was inversely correlated with anti-Rev ELISPOT responses on the day of challenge (P value<0.05), anti-Tat ELISPOT responses at 2 weeks post challenge (P value <0.05) and peak neutralizing antibody titers pre-challenge (P value 0.06). These findings support continued study of recombinant herpesviruses as a vaccine approach for AIDS. 相似文献
20.
The pathogenicity of the primate lentiviruses, human, and simian immunodeficiency viruses, is host-specific. Previous studies indicated that the highly pathogenic human lentivirus HIV-1 has markedly reduced pathogenicity compared to the pathogenic simian lentivirus SIV in pigtail macaques (Macaca nemestrina). We therefore hypothesized that the pigtail macaque peripheral blood mononuclear cells (mPBMCs) would respond differently to infections of HIV-1 and pathogenic SIV. To elucidate the cellular responses to the infections of HIV-1 and SIV, we infected mPBMC with these two viruses. Like infections in vivo, HIV-1 and SIV demonstrated distinct replication kinetics in mPBMCs, with HIV-1 replicating at significantly lower levels. Similarly, gene expression profiling facilitated by macaque-specific oligonucleotide microarrays also revealed distinct expression patterns of genes between the HIV-1- and SIV-infected mPBMCs; in particular, genes associated with the antigen presentation, T cell receptor, ERK/MAPK signaling, Wnt/beta-catenin signaling, and natural killer cell signaling pathways were differentially regulated between these two viruses. Most interestingly, despite the lower levels of replication, HIV-1 triggered a more robust regulation of immune response genes early after infection; the converse was true in SIV-infected mPBMCs. Our results therefore suggest that macaques may be controlling the infection of HIV-1 at an early stage through coordinated regulation of host defense pathways. 相似文献